Agilent Acquires Lab901 to Bolster Electrophoresis Play; Will Evaluate Potential Dx Apps | GenomeWeb

By Ben Butkus

Agilent Technologies this week beefed up its automated electrophoresis and genetic analysis portfolio by acquiring Scottish company Lab901 for an undisclosed amount.

The acquisition is expected to complement Agilent's existing commercial offerings for gel electrophoresis through the addition of Lab901's automated benchtop gel electrophoresis system and associated consumables.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.